Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|May 22, 2025
Brief analysis of Nav1.7 inhibitors: Mechanism of action and new research trendsZhoujun Dong, Baichen Xiong, Tianyu Sun, et al.Chinese Journal of Natural Medicines|October 20, 2024
New insight into targeting the DNA damage response in the treatment of glioblastomaTengfei Zhen, Tianyu Sun, Baichen Xiong, et al.Medicinal Research Reviews|October 26, 2020
Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolismShuaishuai Xing, Qi Li, Baichen Xiong, et al.Bioorganic & Medicinal Chemistry|August 9, 2025
Aging and anti-aging strategies: A review of past and future therapeuticsYuqing Wei, Baichen Xiong, Zuoaoyun Song, et al.Current Medicinal Chemistry|September 16, 2022
Medicinal Prospects of Targeting Tyrosinase: A Feature ReviewYuanyuan Wang, Baichen Xiong, Shuaishuai Xing, et al.Journal of Medicinal Chemistry|September 10, 2021
Strategies for Structural Modification of Small Molecules to Improve Blood-Brain Barrier Penetration: A Recent PerspectiveBaichen Xiong, Yuanyuan Wang, Ying Chen, et al.ACS Chemical Neuroscience|October 2, 2024
Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?Baichen Xiong, Zuoaoyun Song, Leyan Wang, et al.ACS Chemical Neuroscience|December 9, 2021
Discovery of Resorcinol-Based Polycyclic Structures as Tyrosinase Inhibitors for Treatment of Parkinson's DiseaseQi Li, Jun Mo, Baichen Xiong, et al.International Journal of Biological Macromolecules|November 8, 2020
Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screeningShuaishuai Xing, Ying Chen, Baichen Xiong, et al.Biochemical Pharmacology|June 10, 2026
FSP1, a key ferroptosis suppressor with therapeutic potentialXiaoxue Bai, Jiawei Zhu, Baichen Xiong, et al.Pageof 3